Neurofilament Light Chain as a Biomarker of Neuronal Damage in Children With Malaria
The Journal of Infectious Diseases · 12.01.2024 · 229 (1) · 183-188
DOI: 10.1093/infdis/jiad373 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 30.08.2023. Verfasst von Núria Balanza und 9 weiteren Autor:innen. Beteiligte Einrichtung: ISGlobal, Hospital Clinic-University of Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Brain Injuries, Malaria. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research, Canada Research Chair in Molecular Parasitology.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Malaria can cause brain injury. Neurofilament light chain (NfL) is a biomarker of neuronal damage. Here we examined longitudinal plasma NfL levels in children aged 1–12 years with uncomplicated and severe malaria from Mozambique. NfL levels were similar in all malaria cases at hospital admission. However, levels increased over time and the increment was significantly higher in severe malaria cases with neurological manifestations (ie, coma, impaired consciousness, or repeated seizures). NfL may be useful to identify and quantify brain injury in malaria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- ISGlobal, Hospital Clinic-University of Barcelona, Barcelona, Spain.
- Sandra-Rotman Centre for Global Health, Toronto General Research Institute, University Health Network-Toronto General Hospital, Toronto, Ontario, Canada.
- Tropical Disease Unit, Division of Infectious Diseases, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
- Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.
- Pediatrics Department, Hospital Sant Joan de Déu-University of Barcelona, Barcelona, Spain.
ORCID-Profile: Núria Balanza, Valerie M Crowley, Andrea M Weckman, Bàrbara Baro, Rosauro Varo, Quique Bassat, Kevin C Kain
Förderung
- CIHR
- Canadian Institutes of Health Research
- Canada Research Chair in Molecular Parasitology
- Thomas Mather Fund
- Spanish Ministry of Science and Innovation
- Generalitat de Catalunya
- Fundación Ramón Areces
- Centro de Investigação em Saúde de Manhiça
Zitieren
APA
Balanza, N., Francis, C. K., Crowley, V. M., Weckman, A. M., Zhong, K., Baro, B., Varo, R., Bassat, Q., Kain, K. C., & Rosiglitazone Adjunctive Therapy for Severe Malaria in Children (ROSI) Study Group (2024). Neurofilament Light Chain as a Biomarker of Neuronal Damage in Children With Malaria. The Journal of Infectious Diseases, 229(1), 183-188. https://doi.org/10.1093/infdis/jiad373
Vancouver
Balanza N, Francis CK, Crowley VM, Weckman AM, Zhong K, Baro B, et al. Neurofilament Light Chain as a Biomarker of Neuronal Damage in Children With Malaria. The Journal of Infectious Diseases. 2024;229(1):183-188. doi:10.1093/infdis/jiad373
BibTeX
@article{Balanza2024,
author = {Balanza, Núria and Francis, Caroline K and Crowley, Valerie M and Weckman, Andrea M and Zhong, Kathleen and Baro, Bàrbara and Varo, Rosauro and Bassat, Quique and Kain, Kevin C and Rosiglitazone Adjunctive Therapy for Severe Malaria in Children (ROSI) Study Group, Rosiglitazone Adjunctive Therapy for Severe Malaria in Children (ROSI) Study Group},
title = {Neurofilament Light Chain as a Biomarker of Neuronal Damage in Children With Malaria},
journal = {The Journal of Infectious Diseases},
year = {2024},
volume = {229},
number = {1},
pages = {183--188},
doi = {10.1093/infdis/jiad373}
}
EUVIMED